Bernhard H. Dodell

Leads Integration of Covance & Chiltern in Operations. multinational strategic leadership for 22 countries in W-Europe & MEA, oversees clinical trials, regional quality management. Recruit and direct leadership teams. Promote performance excellence, productivity &employee engagement. Manage all P&L, profitability, cost control. Geographic optimisation, vendor management. Inspection readiness, FDA inspections. Recruited country heads. Qualified PartnerCROs

Multinational strategic leadership for 28 EMEA countries, oversees clinical trials, regional quality management. Recruit and direct leadership teams. Promote performance excellence, productivity &employee engagement. Manage all P&L, profitability, cost control. Geographic optimisation, vendor management. Inspection readiness, FDA inspections. Instrumental in risk-based quality control strategy. Recruited country heads. Established Flexible Solutions Model. Qualified PartnerCROs

Managed W-European operational strategy,Israel &South Africa – overseeing qualification &management of subCRO partners, regional business strategy, and resource allocation for all country and regional clinical research projects. Head of Covance CAPS GmbH (Prokurist) Germany, and Managing Director of Covance Austria GmbH. Office expansion and relocation for Covalence Germany. Led the Covance EMEA Geographic Optimisation Initiative. Achieved entry into South Africa and Turkey.

Served on the European Senior Management Leadership Team in Late Stage Development Services. Provided oversight for the region, managing all country leads and key contacts for 7 targeted therapeutic areas. Defined optimised processes and policies for regional clinical operations and projects. Promoted operational excellence and Six Sigma initiatives.

Guided a key emerging region throughout all clinical operations, leading country managers in Russia, Poland, Bulgaria, and Romania. Chaired the Russia Clinical Research Task Force and all revenue growth activities. Ensured flawless business continuity during the 6-month leadership transition. Established the Covance legal and operating entity in Romania. Boosted Romanian business 80%, with all Baltic and CEE countries rising 50% overall. Improved Russian growth by 40% via a major improvement initiative.

Led regional recruitment activities, with authority over performance and training for 50 clinical operations staff. Spearheaded financial performance excellence for clinical operations. Assisted business development and project management teams in all aspects of client relationship management and new business expansion. Promoted European functional consistency and efficiency. Strengthened the local leadership team via a restructuring initiative.

Managed clinical operations for 10 countries in Central and Eastern Europe, overseeing all clinical research business operations, CRO partner oversight, regional study allocation.FDA inspections, internal QA, and corporate audits. Launched new business in Ukraine,Bulgaria &Serbia. Oversaw performance management. Supported medical affairs in relationship building with key opinion leaders. Led Croatia through passing FDA inspection.Fostered relationships with government agencies in Croatia, Ukraine.

Managed two clinical trials for anti-infectives for the systemic antifungal Vfend™ (Voriconazole) global development programme for paediatric indications in the US, UK, and Germany. Supervised CRAs, data managers, statisticians, project planners, and medical writers. Defined all protocols, CRF, and plans.Orchestrated a mission-critical paediatric study for the antifungal compound in alignment with requirements for filing of the paediatric indication and formulation.